Mark Krailo

4PUBLICATIONS
53CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 29, 2025
A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group.

Katherine A Janeway, Alexander J Chou, Allen Buxton

|Feb 20, 2025
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group.

Riaz Gillani, David S Shulman, Natalie J DelRocco

|Oct 02, 2019
Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy.

Gabriele Calaminus, Meriel Jenney, Lars Hjorth

|Jun 26, 2019
Improvements to the Escalation with Overdose Control design and a comparison with the restricted Continual Reassessment Method.

Lingyun Ji, Juan Pablo Lewinger, Mark Krailo

Pageof 1

Frequent Collaborators

2 joint publications

Damon R Reed

1 joint publications

Riaz Gillani

1 joint publications

David S Shulman

1 joint publications

Natalie J DelRocco